Development of novel synthetic promoters for CNS gene therapy

被引：0
|
作者：
Privolizzi, R. [1 ]
Tijani, M. [1 ,2 ]
Oosterveen, T. [2 ]
Giardina, E. [1 ]
Iglesias, J. M. [2 ]
Cooper, S. [2 ]
Waddington, S. N. [1 ,3 ]
Roberts, M. L. [2 ]
Ng, J. [1 ]
机构：
[1] UCL, London, England
[2] Synpromics Ltd, Edinburgh, Midlothian, Scotland
[3] Univ Witwatersrand, Johannesburg, South Africa
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
OR10
引用
收藏
页码：A12 / A12
页数：1
相关论文
共 50 条
  • [31] Gene Therapy for CNS Disorders
    Crystal, R. G.
    HUMAN GENE THERAPY, 2012, 23 (10) : A18 - A18
  • [32] Applications of gene therapy to the CNS
    Blomer, U
    Naldini, L
    Verma, IM
    Trono, D
    Gage, FH
    HUMAN MOLECULAR GENETICS, 1996, 5 : 1397 - 1404
  • [33] The development and characterization of synthetic minimal yeast promoters
    Heidi Redden
    Hal S. Alper
    Nature Communications, 6
  • [34] The development and characterization of synthetic minimal yeast promoters
    Redden, Heidi
    Alper, Hal S.
    NATURE COMMUNICATIONS, 2015, 6
  • [35] Novel hepatocyte-specific synthetic enhancer-promoters for liver targeted gene therapies
    Dudchenko, O.
    Bilski, M.
    Dowding, S. N.
    Gabriel, H. B.
    Williams, J.
    Forsberg, E.
    Broadhurst, B.
    Kompella, P.
    Parker-Manuel, R.
    Brighty, D. W.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A94 - A95
  • [36] Development of Rationally Designed CAG-Based Promoters for Use in Gene Therapy
    Lee, Dustin
    Sullivan, Josefa M.
    Fabela, Natalia
    Hernandez, Edgar
    During, Matthew J.
    Forbes, Alexandria
    Liu, Ce Feng
    MOLECULAR THERAPY, 2023, 31 (04) : 606 - 607
  • [37] Synthetic Promoters for Precise Control of Gene Expression in Plants
    Stewart, C. Neal, Jr.
    Liu, Wusheng
    CHEMICAL ENGINEERING PROGRESS, 2017, 113 (04) : 36 - 39
  • [38] Gene silencing approaches for CNS gene therapy
    Wood, M
    JOURNAL OF GENE MEDICINE, 2004, 6 (09): : S36 - S36
  • [39] Novel disease-specific promoters for use in gene therapy for Parkinson's disease
    Wettergren, E. Elgstrand
    Gussing, F.
    Jansson, E.
    Willassen, Y.
    Quintino, L.
    Lundberg, C.
    HUMAN GENE THERAPY, 2011, 22 (10) : A97 - A97
  • [40] Development of a Synthetic AAV Vector for Gene Therapy of Hemophilia in Children
    Shoti, Jakob
    Qing, Keyun
    Srivastava, Arun
    MOLECULAR THERAPY, 2022, 30 (04) : 332 - 332
12345